Literature DB >> 25229784

To scoop or not to scoop: the diagnostic and therapeutic utility of the scoop-shave biopsy for pigmented lesions.

Gary Mendese1, Mary Maloney, Jeremy Bordeaux.   

Abstract

BACKGROUND: Concern over transection of melanomas has inhibited many practitioners from using the scoop-shave for removal of pigmented lesions.
OBJECTIVE: To assess the safety and efficacy of the scoop-shave for pigmented lesions.
MATERIALS AND METHODS: The practitioner's clinical diagnosis, intent (sample or completely remove), and removal technique (excision, punch, shave biopsy, or scoop-shave) were recorded. Pathology results including the status of the peripheral and deep margins were subsequently documented.
RESULTS: Over an 8-month period, 333 procedures were performed. Of the 11 melanomas (6 in situ and 5 invasive) removed by the scoop-shave, none had positive deep margins and 6 (2 in situ and 4 invasive) were completely removed. One of the 50 dysplastic nevi removed by scoop-shave had a positive deep margin (moderately dysplastic). Forty-six dysplastic nevi were completely removed by the scoop-shave. When the practitioner's intent was "complete removal," the lesion was completely removed 73.1% of the time by scoop-shave, 91% by standard excision, 18.1% by shave biopsy, and 78.6% by punch excision (p < .0001).
CONCLUSION: The scoop-shave is a safe and effective technique for diagnosis and treatment of melanocytic lesions.

Entities:  

Mesh:

Year:  2014        PMID: 25229784     DOI: 10.1097/01.DSS.0000452659.60130.68

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  2 in total

1.  United States Preventive Services Task Force Overstates Cosmetic Harms of Skin Cancer Screening.

Authors:  Joseph F Sobanko; Kimberly Shao; Rebecca L Pearl; Sancy Leachman
Journal:  J Clin Aesthet Dermatol       Date:  2018-04-01

2.  Efficacy and Tolerability of a Novel Biopsy Device for Removing Benign Epidermal Skin Lesions.

Authors:  Steven Hoseong Yang; Ji Qi; Jessica Esandrio; Sherry Leung; Janis M Taube; Luis A Garza; Robert Allen; Sewon Kang; Anna L Chien
Journal:  Dermatol Surg       Date:  2015-11       Impact factor: 3.398

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.